42
Participants
Start Date
October 31, 2005
Primary Completion Date
June 30, 2009
Study Completion Date
January 31, 2011
irinotecan hydrochloride
temozolomide
vincristine sulfate
Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center, New York
SUNY Upstate Medical University Hospital, Syracuse
Lehigh Valley Hospital - Muhlenberg, Bethlehem
Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham, Birmingham
Masonic Cancer Center at University of Minnesota, Minneapolis
Mayo Clinic Cancer Center, Rochester
Children's Memorial Hospital - Chicago, Chicago
Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas, Dallas
Children's Hospital of Orange County, Orange
Children's Hospital and Regional Medical Center - Seattle, Seattle
Stanford Cancer Center, Stanford
Indiana University Melvin and Bren Simon Cancer Center, Indianapolis
Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston
Cincinnati Children's Hospital Medical Center, Cincinnati
Oregon Health and Science University Cancer Institute, Portland
Children's Hospital of Philadelphia, Philadelphia
Hospital for Sick Children, Toronto
Hopital Sainte Justine, Montreal
National Cancer Institute (NCI)
NIH
Children's Oncology Group
NETWORK